Golexanolone is currently under development for the treatment of two disorders –
Primary Biliary Cholangitis (PBC) and Hepatic Encephalopathy (HE).

Primary Biliary Cholangitis (PBC)
Hepatic Encephalopathy (HE)
umecrine-disorders-image (1)